Tirzepatide, often referred to as Mounjaro or Zepbound, has turned out to be an important breakthrough in the treatment of people with type 2 diabetes and obesity. Nonetheless, this medication is expensive, which can discourage many intending patients. Understanding the insurances rules is critical to open tirzepatide to a wider population and at a cheaper […]









